FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — As a means of providing long-term relief from chronic pain, flotation tanks simply don’t hold water, new research reveals. Nearly 100 people plagued by longstanding pain underwent “flotation restricted environmental stimulation therapy” (REST), and the results were disappointing, at least over the longContinue Reading

WEDNESDAY, May 26, 2021 (HealthDay News) — People with spinal cord injuries can overwork their shoulders as they move about in a wheelchair, and that often leads to chronic shoulder pain. However, a small study suggests that an injection of the patient’s own fat cells can help ease the pain.Continue Reading

TUESDAY, May 18, 2021 (HealthDay News) — People suffering from severe obstructive sleep apnea are at a greater risk of catching COVID-19, a new study finds. But researchers at Kaiser Permanente Southern California also found that the longer patients used a continuous positive airway pressure (CPAP) mask while sleeping, theContinue Reading